Delivery Order SPE2DB24D2100-SPE2DB25FBGKA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $7,344.91 for ADDYI 100 mg tablets (30-count units) on July 9, 2025, with an ultimate completion date of July 10, 2025. This non-set-aside contract represents a competitively awarded procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters location of the prime contractor. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.28 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $11.3K to AmerisourceBergen Drug Corp for 30-count tablets of ADDYI 100 mg on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing supply of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,037.90 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units). The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, employs firm fixed-price pricing and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of ADDYI 100 mg tablets (30-count unit dose packaging) with a contract ceiling value of $6,180.54 and an ultimate completion date of August 4, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,935.74 delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) under a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This contract represents a non-set-aside, competitively awarded delivery order, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $5,959.27 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ADDYI (flibansergin) 100 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for ultimate completion on September 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency has awarded a delivery order valued at $4,889.15 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of June 2, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,759.58 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract was executed on July 10, 2025, with an ultimate completion date of July 11, 2025, and utilizes firm fixed pricing. The awardee, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of ADDYI (flibanserins) 100 mg tablets in quantities of 30, with a ceiling value of $2,903.61. This firm fixed-price delivery order, which is expected to be completed by April 25, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGKADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,454.99 on September 16, 2025, for the supply of ADDYI 100 mg tablets in packages of 30. This non-set-aside, competitively awarded delivery order carries a firm fixed price structure and is scheduled for completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as one of the nation's leading pharmaceutical distributors serving federal healthcare systems. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally. AmerisourceBergen's federal contract portfolio demonstrates substantial capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains, positioning the company as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 9/16/25 |